Last reviewed · How we verify
Platelet Rich Plasma
Platelet Rich Plasma (PRP) is a marketed product developed by Wroclaw Medical University, currently without a specified primary indication or revenue data. A key strength of PRP is its patent protection, which extends until 2028, providing a barrier to generic competition. The primary risk is the lack of detailed clinical trial results and identified competitors, which may affect market confidence and adoption.
At a glance
| Generic name | Platelet Rich Plasma |
|---|---|
| Also known as | PRP, Plasma, Platelet Rich, Blood Platelets, PRP Injection, Platelet Concentrate |
| Sponsor | Wroclaw Medical University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- PRP Injection Into the Sacroiliac Joint After Ipsilateral THA: Effects on Early Recovery and Function (SIJ-THA Randomized Trial) (NA)
- Thumb Base Osteoarthritis: Ultrasound-guided Platelet-rich Plasma Versus Placebo Injection (PHASE2)
- PRP as Adjuvant Treatment to CTR for Severe CTS Tunnel Syndrome (NA)
- Identification of Responders to Platelet-Rich Plasma (PRP) Injections in Lateral Elbow Epicondylalgia
- Treatment of Patellofemoral Osteoarthritis With Engineered Cartilage. (PHASE2)
- Subtenon Autologous Platelet-Rich Plasma in Inherited and Degenerative Retinal Diseases (PHASE1, PHASE2)
- Pilot Exploration of Platelet Characterization of Platelet Rich Plasma Created by Two Different Systems (PHASE4)
- Monitoring of Anti-TFPI in Hemophilia
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Platelet Rich Plasma CI brief — competitive landscape report
- Platelet Rich Plasma updates RSS · CI watch RSS
- Wroclaw Medical University portfolio CI